{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:45:16Z","timestamp":1792449916642,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107881","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T02:23:18Z","timestamp":1728526998000},"page":"107881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies"],"prefix":"10.1016","volume":"153","author":[{"given":"Wael A.A.","family":"Fadaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma E.A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed T.M.","family":"Nemr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha H.","family":"Zidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107881_b0005","article-title":"Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2\/AKT dual inhibitors, apoptosis and autophagy inducers","volume":"150","author":"AbdEl-Mawgoud","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104134","article-title":"New fused pyrimidine derivatives with anticancer activity: synthesis, topoisomerase II inhibition, apoptotic inducing activity and molecular modeling study","volume":"103","author":"Nemr","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104446","article-title":"Design, synthesis and anti-proliferative evaluation of new tricyclic fused thiazolopyrimidines targeting topoisomerase II: Molecular docking and apoptosis inducing activity","volume":"105","author":"Nemr","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10100412","article-title":"Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2024.107881_b0025","doi-asserted-by":"crossref","first-page":"26241","DOI":"10.1039\/D1RA05277B","article-title":"Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition","volume":"11","author":"Nemr","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.107881_b0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2015.04.033","article-title":"Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives","volume":"96","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.bioorg.2024.107881_b0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14756366.2018.1446432","article-title":"Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails","volume":"33","author":"Awadallah","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0040","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0055","doi-asserted-by":"crossref","unstructured":"J. R. Casey, P. E. Morgan, D. Vullo, A. Mastrolorenzo, A. Scozzafava, C. T. Supuran, Carbonic anhydrase inhibitors. Design of selective, membrane-Impermeant inhibitors targeting the human tumor-associated isozyme IX, J. Med. Chem. (47) (2004) 2337-2347. DOI: 10.1021\/jm031079w.","DOI":"10.1021\/jm031079w"},{"key":"10.1016\/j.bioorg.2024.107881_b0060","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107881_b0065","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1016\/j.bmcl.2014.05.086","article-title":"Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors","volume":"24","author":"Rosatelli","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107881_b0070","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/molecules20022323","article-title":"Targeting carbonic anhydrase IX activity and expression","author":"Mahon","year":"2015","journal-title":"Molecules (20)"},{"key":"10.1016\/j.bioorg.2024.107881_b0075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrg2665","article-title":"Generating specificity and diversity in the transcriptional response to hypoxia","volume":"10","author":"Lendahl","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bioorg.2024.107881_b0080","first-page":"2585","article-title":"Betulin sulfonamides as carbonic anhydrase inhibitors and anticancer agents in breast cancer cells","volume":"41","author":"G\u00fcttler","year":"2019","journal-title":"Oncol. Rep."},{"issue":"53","key":"10.1016\/j.bioorg.2024.107881_b0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm901524f","article-title":"The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the anti-epileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors","volume":"2","author":"Temperini","year":"2010","journal-title":"J. Med. Chem."},{"issue":"33","key":"10.1016\/j.bioorg.2024.107881_b0090","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1039\/C5CC01854D","article-title":"X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors","volume":"51","author":"Ivanova","year":"2015","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107881_b0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/14756366.2017.1411350","article-title":"Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma","volume":"33","author":"Lucarini","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0100","doi-asserted-by":"crossref","unstructured":"A. Nocentini, S. Bua,C.L.Lomelino,R.McKenna,M.Menicatti,G.Bartolucci,B.Tenci,L.Di Cesare Mannelli,C.Ghelardini,P.Gratteri,C.T.Supuran, Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases, ACS Med. Chem. Lett., 8 (12) (2017) 1314\u20131319. DOI: 10.1021\/acsmedchemlett.7b00399.","DOI":"10.1021\/acsmedchemlett.7b00399"},{"key":"10.1016\/j.bioorg.2024.107881_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116140","article-title":"Developments of small molecules as inhibitors for carbonic anhydrase isoforms","volume":"39","author":"Buabeng","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bioorg.2019.01.002","article-title":"Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors","volume":"85","author":"Sharmaa","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128249","article-title":"Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: design, synthesis, computational and enzyme inhibition studies","volume":"48","author":"Manzoor","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107881_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107154","article-title":"Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity","volume":"144","author":"Abdelhakeem","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105764","article-title":"Tail-approach based design and synthesis of arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors","volume":"123","author":"Kumar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0130","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.bmcl.2015.05.076","article-title":"New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulphonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII","volume":"25","author":"Meleddu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107881_b0135","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/acsmedchemlett.8b00352","article-title":"Tuning the dual inhibition of carbonic anhydrase and cyclooxygenase by dihydrothiazole benzensulphonamides","volume":"9","author":"Meleddu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107881_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106492","article-title":"Arylidine extensions of 3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-benzenesulfonamide derivatives: synthesis, computational simulations and biological evaluation as tumor-associated carbonic anhydrase inhibitors","volume":"135","author":"Metwally","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bioorg.2018.02.021","article-title":"Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy","volume":"77","author":"Nocentini","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107881_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2016.07.114","article-title":"Structural insight into the inhibition of carbonic anhydrase by the COX-2-selective inhibitor polmacoxib (CG100649)","volume":"478","author":"Kim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"27","key":"10.1016\/j.bioorg.2024.107881_b0155","doi-asserted-by":"crossref","first-page":"18461","DOI":"10.1039\/D3RA03276K","article-title":"Synthesis, characterization and biological evaluation of pyrazole-based benzene sulfonamides as inhibitors of human carbonic anhydrase II, IX and XII","volume":"13","author":"Hussain","year":"2023","journal-title":"RSC Adv."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107881_b0160","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.3390\/molecules26227023","article-title":"Carbonic anhydrase inhibition with sulfonamides incorporating pyrazole- and pyridazinecarboxamide moieties provides examples of isoform-selective inhibitors","volume":"26","author":"Angeli","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107881_b0165","article-title":"New pyrazolyl-thiazolidinone\/thiazole derivatives as celecoxib\/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory\/anti-proliferative activities, apoptosis, molecular modeling and ADME studies","volume":"38","author":"Fadaly","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106428","article-title":"Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities","volume":"134","author":"Fadaly","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107623","article-title":"Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives","volume":"150","author":"Ewieda","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107881_b0180","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2290461","article-title":"Abdellatif, New 1,2,3-triazole\/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib analogs","volume":"38","author":"Fadaly","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107403","article-title":"Discovery of novel pyrazole based urea\/thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M Tyrosine Kinases and COX-2 inhibitors, with anti-cancer and anti-inflammatory activities","volume":"147","author":"Fadaly","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107410","article-title":"Novel guanidine derivatives targeting leukemia as selective Src\/Abl dual inhibitors: design, synthesis and anti-proliferative activity","volume":"147","author":"Moustafa","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0195","doi-asserted-by":"crossref","unstructured":"S. Siliveri, N. Bashaboina, H. B. Vamaraju, S. Raj, Design, synthesis, molecular docking, ADMET studies, and biological evaluation of isoxazoline and pyrazoline incorporating 1,2,3-triazole benzene sulfonamides, Rus. Bioorg. Chem. (45) 5 (2019) 381-390. DOI: 10.1134\/S1068162019050108.","DOI":"10.1134\/S1068162019050108"},{"key":"10.1016\/j.bioorg.2024.107881_b0200","doi-asserted-by":"crossref","unstructured":"S. Siliveri, N. Bashaboina, H. B. Vamaraju, S. Raj, Design, synthesis, molecular docking, ADMET studies and biological evaluation of pyrazoline incorporated 1,2,3-triazole benzene sulphonamides, Int. J. Pharm. Sci. (11) 6 (2019) 6-15. DOI: http:\/\/dx.doi.org\/10.22159\/ijpps.2019v11i6.32684.","DOI":"10.22159\/ijpps.2019v11i6.32684"},{"key":"10.1016\/j.bioorg.2024.107881_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112745","article-title":"3-Methylthiazolo[3,2-a] benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies","volume":"207","author":"Alkhaldi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/14756366.2017.1356295","article-title":"Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo [d] thiazole-5- and 6-sulfonamides","volume":"32","author":"Abdoli","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2024.107881_b0215","first-page":"9545","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Research Article"},{"key":"10.1016\/j.bioorg.2024.107881_b0220","article-title":"Valentina Onnisa, Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors","volume":"98","author":"Moia","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111698","article-title":"Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors","volume":"183","author":"Vats","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0230","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1080\/14756366.2018.1513927","article-title":"Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates","volume":"33","author":"El-gazzar","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107881_b0240","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2024.107881_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107566","article-title":"Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2\/GSK3\u03b2 kinase inhibitors; molecular docking study, and ADME prediction","volume":"150","author":"Nemr","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0250","unstructured":"N. M. O'Boyle, M. Banck, C. A. James, C. Morley, T. Vandermeersch, G. R. Hutchison, J. Chem. Inform. (3) 33 (2011). https:\/\/doi.org\/10. 1186\/1758-2946-3-33."},{"key":"10.1016\/j.bioorg.2024.107881_b0255","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"(30) 16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107881_b0260","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107881_b0265","doi-asserted-by":"crossref","unstructured":"P. Eastman, M. S. Friedrichs, J. D. Chodera, R. J. Radmer, C. M. Bruns, J. P. Ku, K. A. Beauchamp, T. J. Lane, L. P. Wang, D. Shukla, T. Tye, M. Houston, T. Stich, C. Klein, M. R. Shirts, V. S. Pande, J. Chem. Theory Comput. 9 (2013) 461. https:\/\/doi.org\/10.1021\/ct300857j.","DOI":"10.1021\/ct300857j"},{"key":"10.1016\/j.bioorg.2024.107881_b0270","first-page":"243","article-title":"Small-molecule library screening by docking with PyRx","author":"Dallakyan","year":"2014","journal-title":"Chem. Bio."},{"key":"10.1016\/j.bioorg.2024.107881_b0275","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2024.107881_b0280","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107881_b0285","doi-asserted-by":"crossref","first-page":"673a","DOI":"10.1016\/j.bpj.2017.11.3632","article-title":"QwikMD-gateway for easy simulation with VMD and NAMD","volume":"114","author":"Ribeiro","year":"2018","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107881_b0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2024.107881_b0295","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA. py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:25:41Z","timestamp":1738185941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"alternative-id":["S0045206824007867"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107881","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107881"}}